Edap Tms (NASDAQ:EDAP) PT Raised to $12.00

Edap Tms (NASDAQ:EDAPGet Rating) had its price objective upped by stock analysts at Piper Sandler from $11.00 to $12.00 in a research report issued to clients and investors on Thursday, The Fly reports. Piper Sandler’s price target would suggest a potential upside of 20.60% from the stock’s previous close.

A number of other equities research analysts also recently issued reports on the stock. StockNews.com initiated coverage on shares of Edap Tms in a research report on Wednesday, October 12th. They set a “hold” rating for the company. Jefferies Financial Group initiated coverage on shares of Edap Tms in a research note on Tuesday, November 1st. They set a “buy” rating and a $11.00 target price on the stock.

Edap Tms Trading Down 3.8 %

Shares of EDAP stock opened at $9.95 on Thursday. Edap Tms has a 1 year low of $5.13 and a 1 year high of $10.60. The firm has a fifty day moving average price of $8.86 and a 200-day moving average price of $7.72. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.58 and a quick ratio of 3.18. The company has a market cap of $359.64 million, a price-to-earnings ratio of 90.46 and a beta of 1.22.

Edap Tms (NASDAQ:EDAPGet Rating) last issued its quarterly earnings data on Wednesday, August 24th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.09. Edap Tms had a net margin of 6.76% and a return on equity of 6.87%. The firm had revenue of $14.97 million during the quarter, compared to the consensus estimate of $14.17 million. As a group, equities analysts predict that Edap Tms will post 0.02 earnings per share for the current year.

Institutional Trading of Edap Tms

Several hedge funds have recently bought and sold shares of EDAP. Camarda Financial Advisors LLC purchased a new stake in Edap Tms in the 1st quarter worth $209,000. JPMorgan Chase & Co. purchased a new stake in Edap Tms in the 1st quarter worth $60,000. HighTower Advisors LLC purchased a new stake in Edap Tms in the 1st quarter worth $185,000. Rock Springs Capital Management LP lifted its stake in Edap Tms by 7.8% in the 1st quarter. Rock Springs Capital Management LP now owns 820,000 shares of the medical equipment provider’s stock worth $5,945,000 after purchasing an additional 59,100 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its holdings in shares of Edap Tms by 8.3% in the 2nd quarter. Commonwealth Equity Services LLC now owns 52,225 shares of the medical equipment provider’s stock worth $355,000 after buying an additional 4,000 shares during the last quarter. Hedge funds and other institutional investors own 28.53% of the company’s stock.

About Edap Tms

(Get Rating)

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).

Featured Articles

The Fly logo

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.